H19 and glioblastoma: In malignant gliomas (GBM), lnc-H19 encodes the 256-aa peptide H19-IRP, which promotes myeloid-derived suppressor cells (MDSCs) and TAM infiltration, as well as T cell depletion, essential for forming an immunosuppressive GBM microenvironment.